The Research and Development team at Gyroscope Therapeutics focuses on advancing innovative gene therapies aimed at treating dry age-related macular degeneration and other retinal diseases. Comprising experts in biology, translational research, and analytical development, the team collaborates to design, develop, and optimize therapies, ensuring robust preclinical and clinical validation to bring effective treatments to patients.
View all